• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Elucidation of cancer proliferation mechanisms based on signal transduction from organelles different from normal cells

Research Project

Project/Area Number 19H03722
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Review Section Basic Section 55010:General surgery and pediatric surgery-related
Research InstitutionNational Institutes of Biomedical Innovation, Health and Nutrition (2020-2021)
National Cancer Center Japan (2019)

Principal Investigator

Nishida Toshirou  国立研究開発法人医薬基盤・健康・栄養研究所, 医薬基盤研究所 細胞核輸送ダイナミクスプロジェクト, 客員研究員 (40263264)

Co-Investigator(Kenkyū-buntansha) 小幡 裕希  国立研究開発法人国立がん研究センター, 研究所, ユニット長 (20609408)
市川 仁  国立研究開発法人国立がん研究センター, 先端医療開発センター, ユニット長 (30201924)
黒川 量雄  国立研究開発法人理化学研究所, 光量子工学研究センター, 専任研究員 (40333504)
眞鍋 史乃  星薬科大学, 薬学部, 教授 (60300901)
Project Period (FY) 2019-04-01 – 2022-03-31
Project Status Completed (Fiscal Year 2021)
Budget Amount *help
¥17,550,000 (Direct Cost: ¥13,500,000、Indirect Cost: ¥4,050,000)
Fiscal Year 2021: ¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2020: ¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2019: ¥9,230,000 (Direct Cost: ¥7,100,000、Indirect Cost: ¥2,130,000)
KeywordsReceptor tyrosine kinase / Driver mutation / オルガネラ / シグナル伝達機構 / KIT / GIST / receptor tyrosine kinase / driver mutation / チロシンキナーゼ / 細胞内局在 / ゴルジ体 / エンドソーム / キナーゼ活性化 / がん / ドライバー変異 / 局在異常 / チロシンリン酸化シグナル
Outline of Research at the Start

がん原性変異を持ったキナーゼは,野生型とは異なる細胞内オルガネラに集積して活性化している。本研究では、
1年目には、細胞株を用い、新たに発見された変異キナーゼの細胞内局在と、それらオルガネラへの集積機構を解明し、併せて、オルガネラでの変異キナーゼの活性化条件を明らかにする。
2年目には、特定のオルガネラでの下流シグナル伝達系の活性化のメカニズムを明らかにする。同時に、臨床検体を用いキナーゼ変異体の細胞内局在化と活性化を明らかにし、その臨床的意義を明らかにする。
3年目には、オルガネラへの変異キナーゼの集積に直接関わる分子を明らかにし、ノックダウン等でその分子の関与とメカニズムを明らかにする。

Outline of Final Research Achievements

The purpose of the study is to elucidate the molecular mechanism of intracellular localization of mutant kinases. In this study, we identified the molecules responsible for transport of KIT from ER to the Golgi apparatus using methods, such as siRNA. Next, in GIST, activated mutant KIT is abnormally localized around the Golgi apparatus. Our data obtained from immune-coprecipitation and siRNA indicate that several molecules (3 kinases and multiple anchor proteins) are involved in abnormal localization of mutant KIT in the trans-Golgi and that these molecules are sequentially phosphorylated and finally activated mutant KIT is transferred to specific anchor molecules to localize in trans-Golgi. In near future, we will elucidate detailed subcellular localization of mutant KIT and mechanism of proliferation signaling from there using a three-dimensional super-resolution analysis.

Academic Significance and Societal Importance of the Research Achievements

膜型チロシンキナーゼを始め殆どの膜タンパク質は、小胞体で作られゴルジを通り細胞膜等に小胞輸送される。本研究でKITの小胞体からゴルジ体への小胞輸送に関連する分子を同定したことで、KIT特異的に小胞体→ゴルジの小胞輸送を阻害する抗癌剤開発の可能性が確認できた。また、リン酸化した変異KITのゴルジ異常局在に関与するキナーゼ群を見つけ、これらの阻害剤は変異KIT特異的に作用し、細胞死を導いた。これら阻害剤は、二次遺伝子変異等で耐性になった様々なGISTにも幅広く効果のある薬剤として期待される。この手法は、他のチロシンキナーゼ変異をドライバーとして持つ癌腫の新規治療薬の開発としても期待される。

Report

(4 results)
  • 2021 Annual Research Report   Final Research Report ( PDF )
  • 2020 Annual Research Report
  • 2019 Annual Research Report
  • Research Products

    (24 results)

All 2021 2020 2019

All Journal Article (17 results) (of which Int'l Joint Research: 6 results,  Peer Reviewed: 16 results,  Open Access: 13 results) Presentation (7 results) (of which Int'l Joint Research: 2 results,  Invited: 5 results)

  • [Journal Article] FLT3-ITD transduces autonomous growth signals during its biosynthetic trafficking in acute myelogenous leukemia cells2021

    • Author(s)
      Yamawaki K, Shiina I, Murata T, Tateyama S, Maekawa Y, Niwa M, Shimonaka M, Okamoto K, Suzuki T, Nishida T, Abe R, Obata Y.
    • Journal Title

      Sci Rep

      Volume: 11 Issue: 1 Pages: 22678-22678

    • DOI

      10.1038/s41598-021-02221-2

    • URL

      https://pure.teikyo.jp/en/publications/96981d03-7101-4475-85d4-44ea93511707

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Impact of the KIT/PDGFRA genotype on prognosis in imatinib‐naive Japanese patients with gastrointestinal stromal tumor2021

    • Author(s)
      Cho H, Nishida T, Takahashi T, Masuzawa T, Hirota S.
    • Journal Title

      Ann Gastroenterol Surg

      Volume: 6 Issue: 2 Pages: 241-248

    • DOI

      10.1002/ags3.12527

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Targeted therapy for drug-tolerant persister cells after imatinib treatment for gastrointestinal stromal tumours.2021

    • Author(s)
      Ishida T, Takahashi T, Kurokawa Y, Nishida T, Hirota S, Serada S, Fujimoto M, Naka T, Teranishi R, Saito T, Yamashita K, Tanaka K, Yamamoto K, Makino T, Yamasaki M, Nakajima K, Eguchi H, Doki Y.
    • Journal Title

      Br J Cancer

      Volume: 125 Issue: 11 Pages: 1511-1522

    • DOI

      10.1038/s41416-021-01566-9

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Targeted therapy for drug-tolerant persister cells after imatinib treatment for gastrointestinal stromal tumours2021

    • Author(s)
      Ishida T, Takahashi T, Kurokawa Y, Nishida T, Hirota S, Serada S, Fujimoto M, Naka T, Teranishi R, Saito T, Yamashita K, Tanaka K, Yamamoto K, Makino T, Yamasaki M, Nakajima K, Eguchi H, Doki Y.
    • Journal Title

      Br J Cancer

      Volume: 125 Issue: 13 Pages: 1511-1522

    • DOI

      10.3390/cancers13133158

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Gastrointestinal stromal tumours.2021

    • Author(s)
      Blay, JY., Kang, YK., Nishida, T. von Mehren M.
    • Journal Title

      Nat Rev Dis Primers

      Volume: 7 Issue: 1 Pages: 22-22

    • DOI

      10.1038/s41572-021-00254-5

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed / Int'l Joint Research
  • [Journal Article] A New Approach to Refractory GIST with Diverse Acquired Mutations.2020

    • Author(s)
      Nishida T, Doi T.
    • Journal Title

      Lancet Oncol.

      Volume: 21 Issue: 7 Pages: 864-865

    • DOI

      10.1016/s1470-2045(20)30209-6

    • Related Report
      2020 Annual Research Report
    • Open Access / Int'l Joint Research
  • [Journal Article] MASTER KEY Project: Powering Clinical Development for Rare Cancers through a Platform Trial2020

    • Author(s)
      Okuma Hitomi S、Yonemori Kan、Narita Shoko N、Sukigara Tamie、Hirakawa Akihiro、Shimizu Toshio、Shibata Taro、Kawai Akira、Yamamoto Noboru、Nakamura Kenichi、Nishida Toshiro、Fujiwara Yasuhiro
    • Journal Title

      Clinical Pharmacology & Therapeutics

      Volume: - Issue: 3 Pages: 596-605

    • DOI

      10.1002/cpt.1817

    • Related Report
      2020 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] TAS-116 inhibits oncogenic KIT signalling on the Golgi in both imatinib-naive and imatinib-resistant gastrointestinal stromal tumours.2020

    • Author(s)
      Saito Y, Takahashi T, Obata Y, Nishida T, Ohkubo S, Nakagawa F, Serada S, Fujimoto M, Ohkawara T, Nishigaki T, Sugase T, Koh M, Ishida T, Tanaka K, Miyazaki Y, Makino T, Kurokawa Y, Nakajima K, Yamasaki M, Hirota S, Naka T, Mori M, Doki Y.
    • Journal Title

      Br. J. Cancer.

      Volume: 122 Issue: 5 Pages: 658-667

    • DOI

      10.1038/s41416-019-0688-y

    • Related Report
      2020 Annual Research Report 2019 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Rare cancers in Japan: definition, clinical features and future perspectives2020

    • Author(s)
      Kawai Akira、Higashi Takahiro、Shibata Taro、Yoshida Akihiko、Katoh Yoko、Fujiwara Yasuhiro、Nishida Toshirou
    • Journal Title

      Japanese Journal of Clinical Oncology

      Volume: 50 Issue: 9 Pages: 970-975

    • DOI

      10.1093/jjco/hyaa121

    • Related Report
      2020 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Is surgery alone sufficient for treating T1 gastric cancer with extensive lymph node metastases?2020

    • Author(s)
      Yura M, Yoshikawa T, Otsuki S, Yamagata Y, Morita S, Katai H, Nishida T.
    • Journal Title

      Gastric Cancer

      Volume: 24 Issue: 2 Pages: 349-355

    • DOI

      10.1007/s10120-019-01006-x

    • NAID

      40022173313

    • Related Report
      2019 Annual Research Report
    • Peer Reviewed
  • [Journal Article] BRAF V600E mutation is a potential therapeutic target for a small subset of synovial sarcoma.2020

    • Author(s)
      Watanabe S, Shimomura A, Kubo T, Sekimizu M, Seo T, Watanabe SI, Kawai A, Yamamoto N, Tamura K, Kohno T, Ichikawa H, Yoshida A.
    • Journal Title

      Mod. Pathol.

      Volume: - Issue: 9 Pages: 1660-1668

    • DOI

      10.1038/s41379-020-0530-3

    • Related Report
      2019 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Adherence to the guidelines and the pathological diagnosis of high-risk gastrointestinal stromal tumors in the real world2019

    • Author(s)
      Nishida T, Sakai Y, Takagi M, Ozaka M, Kitagawa Y, Kurokawa Y, Masuzawa T, Naito Y, Kagimura T, Hirota S, and the members of the STAR ReGISTry Study Group
    • Journal Title

      Gastric Cancer

      Volume: 印刷中 Issue: 1 Pages: 118-125

    • DOI

      10.1007/s10120-019-00966-4

    • NAID

      120006786938

    • Related Report
      2019 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Large-Scale, Prospective Observational Study of Regorafenib in Japanese Patients with Metastatic Colorectal Cancer in a Real-World Clinical Setting.2019

    • Author(s)
      Yamaguchi K, Komatsu Y, Satoh T, Uetake H, Yoshino T, Nishida T, Yamazaki N, Takikawa H, Morimoto T, Chosa M, Sunaya T, Hamada Y, Muro K, Sugihara K.
    • Journal Title

      Oncologist

      Volume: - Issue: 7 Pages: 450-457

    • DOI

      10.1634/theoncologist.2018-0377

    • Related Report
      2019 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Efficacy and safety of TAS-116, an oral inhibitor of heat shock protein 90, in patients with metastatic or unresectable gastrointestinal stromal tumour refractory to imatinib, sunitinib and regorafenib: a phase II, single-arm trial.2019

    • Author(s)
      Doi T, Kurokawa Y, Sawaki A, Komatsu Y, Ozaka M, Takahashi T, Naito Y, Ohkubo S, Nishida T.
    • Journal Title

      Eur. J. Cancer

      Volume: 121 Pages: 29-39

    • DOI

      10.1016/j.ejca.2019.08.009

    • Related Report
      2019 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] N822K- or V560G-mutated KIT activation preferentially occurs in lipid rafts of the Golgi apparatus in leukemia cells.2019

    • Author(s)
      Obata Y, Hara Y, Shiina I, Murata T, Tasaki Y, Suzuki K, Ito K, Tsugawa S, Yamawaki K, Takahashi T, Okamoto K, Nishida T, Abe R.
    • Journal Title

      Cell Commun. Signal.

      Volume: 4 Issue: 1 Pages: 114-114

    • DOI

      10.1186/s12964-019-0426-3

    • Related Report
      2019 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] NOX1-Dependent mTORC1 Activation via S100A9 Oxidation in Cancer Stem-like Cells Leads to Colon Cancer Progression2019

    • Author(s)
      Ohata H, Shiokawa D, Obata Y, Sato A, Sakai H, Fukami M, Hara W, Taniguchi H, Ono M, Nakagama H, Okamoto K.
    • Journal Title

      Cell Rep.

      Volume: 28 Issue: 5 Pages: 1282

    • DOI

      10.1016/j.celrep.2019.06.085

    • URL

      https://localhost/en/publications/fe163b96-075a-449b-8338-0cfbd1a7ce03

    • Related Report
      2019 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Defining Tumor Rupture in Gastrointestinal Stromal Tumor.2019

    • Author(s)
      Nishida T, Holmebakk T, Raut CP, Rutkowski P.
    • Journal Title

      Ann Surg Oncol.

      Volume: - Issue: 6 Pages: 1669-1675

    • DOI

      10.1245/s10434-019-07297-9

    • Related Report
      2019 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Presentation] New Advances in GIST Treatment in Japan and Value of Long-Term Adjuvant Treatment for High Risk GISTs2020

    • Author(s)
      Toshirou Nishida
    • Organizer
      GISTour
    • Related Report
      2020 Annual Research Report
    • Int'l Joint Research / Invited
  • [Presentation] 希少がん診療の現状2020

    • Author(s)
      西田俊朗
    • Organizer
      令和2年度 第1回大阪府がん診療連携協議会
    • Related Report
      2020 Annual Research Report
    • Invited
  • [Presentation] 変異型Kitチロシンキナーゼのゴルジ体への異常局在とそこから発信される増殖シグナル ~ GIST・急性骨髄性白血病におけるオルガネラシグナル ~2019

    • Author(s)
      小幡裕希, 原 泰志, 椎名 勇, 村田貴嗣, 津川 翔, 山脇康平, 高橋 剛, 岡本康司, 西田俊朗, 安部 良
    • Organizer
      第19回 日本蛋白質科学会年会・第71回 日本細胞生物学会大会
    • Related Report
      2019 Annual Research Report
  • [Presentation] ゴルジ体内の積荷タンパク質輸送の可視化2019

    • Author(s)
      黒川量雄,中野明彦
    • Organizer
      第19回 日本蛋白質科学会年会・第71回 日本細胞生物学会大会
    • Related Report
      2019 Annual Research Report
  • [Presentation] Visualization of cargo transport from the ER to the Golgi and within the Golgi.2019

    • Author(s)
      Kazuo Kurokawa
    • Organizer
      RIKEN symposium: Cutting edge of membrane traffic
    • Related Report
      2019 Annual Research Report
    • Int'l Joint Research / Invited
  • [Presentation] 成熟するゴルジ槽内のゾーン形成と積荷タンパク質輸送の可視化2019

    • Author(s)
      黒川量雄
    • Organizer
      第38回 日本糖質学会年会
    • Related Report
      2019 Annual Research Report
    • Invited
  • [Presentation] 4Dイメージングによる小胞体-ゴルジ体間,ゴルジ体内の蛋白質輸送機構2019

    • Author(s)
      黒川量雄
    • Organizer
      日本遺伝学会 第91回大会
    • Related Report
      2019 Annual Research Report
    • Invited

URL: 

Published: 2019-04-18   Modified: 2023-01-30  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi